Heptane
Medchemexpress LLC rel-Zotatifin | 2098191-54-7 | 97.3% | 487.56 g/mol | C28H29N3O5 | 5 MG
rel-Zotatifin is a research-grade small-molecule inhibitor of the eukaryotic initiation factor eIF4A, supplied as the racemic isomer for laboratory studies. It is characterized by a molecular formula of C28H29N3O5, molecular weight of 487.56 g/mol, and high purity suitable for biochemical and cellular assays.
- Racemic isomer with eIF4A inhibitory activity.
- High supplied purity for research applications.
- Supplied as a small, convenient 5 mg package for screening and assay development.
- Suitable for biochemical and cell-based translation studies.
- Molecular weight and formula provided for analytical confirmation.
Medchemexpress LLC Cyclosomatostatin | 84211-54-1 | 99.76% | 779.97 | 5 MG
Cyclosomatostatin is a potent somatostatin (SST) receptor antagonist that inhibits somatostatin receptor type 1 (SSTR1) signaling. It has been shown to decrease cell proliferation, ALDH+ cell population size, and sphere-formation in colorectal cancer (CRC) cells.
- Potent somatostatin receptor antagonist
- Inhibits somatostatin receptor type 1 (SSTR1) signaling
- Decreases cell proliferation
- Reduces ALDH+ cell population size
- Reduces sphere-formation in colorectal cancer (CRC) cells
![Medchemexpress LLC 2-[[4-[(2-methoxybenzoyl)amino]benzoyl]amino]benzoic acid | 693241-54-2 | MFCD03624354 | 98.3% | 390.39 g/mol | C22H18N2O5 | 25MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000236164.png-250.jpg)
Medchemexpress LLC 2-[[4-[(2-methoxybenzoyl)amino]benzoyl]amino]benzoic acid | 693241-54-2 | MFCD03624354 | 98.3% | 390.39 g/mol | C22H18N2O5 | 25MG
EG1 is a small-molecule inhibitor of the Pax2 transcription factor that binds the paired domain (Kd 1.35-1.5 μM) and disrupts Pax2-DNA interactions; provided as a solid research reagent for in vitro studies.
![Medchemexpress LLC 2-propenamide, 3-(3-chlorophenyl)-N-[2-[4-(methylsulfonyl)-1-piperazinyl]-2-oxoethyl]-, (2E)- | 2505001-54-5 | 100.0% | 385.87 g·mol-1 | C16H20ClN3O4S | 5 MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000221429.png-250.jpg)
Medchemexpress LLC 2-propenamide, 3-(3-chlorophenyl)-N-[2-[4-(methylsulfonyl)-1-piperazinyl]-2-oxoethyl]-, (2E)- | 2505001-54-5 | 100.0% | 385.87 g·mol-1 | C16H20ClN3O4S | 5 MG
SR15006 is a small-molecule inhibitor of Krüppel-like factor 5 (KLF5) supplied as a high-purity research reagent. It has reported activity in cell-based assays (IC50 = 41.6 nM in DLD-1/pGL4.18hKLF5p cells) and is provided with solubility and storage guidance for in vitro and in vivo use.
- Inhibits KLF5 with IC50 = 41.6 nM in DLD-1/pGL4.18hKLF5p cells.
- High purity suitable for research applications.
- Soluble in DMSO at 100 mg/mL; example in vivo formulations provided.
- Recommended storage: solid at 4°C; in solution -80°C (6 months) or -20°C (1 month).
- Molecular formula C16H20ClN3O4S; molecular weight 385.87 g·mol-1.
- For research use only; not for human or clinical use.
eMolecules 76928-54-6 | 2-ETHYNYLTETRAHYDROFURAN | AstaTech | MFCD26853295 | 96.129 | C6H8O | 95.000 | C#CC1CCCO1 | 0.1g | 503283468
2-ETHYNYLTETRAHYDROFURAN | AstaTech | 76928-54-6 | MFCD26853295 | 96.129 | C6H8O | 95.000 | C#CC1CCCO1 | 0.1g | 503283468
![Medchemexpress LLC 2-cyano-N-{[(3,4-dichlorophenyl)carbamothioyl]amino}acetamide | 656222-54-7 | MFCD00119122 | 99.8% | 303.17 | C10H8Cl2N4OS | 25MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000237141.png-250.jpg)
Medchemexpress LLC 2-cyano-N-{[(3,4-dichlorophenyl)carbamothioyl]amino}acetamide | 656222-54-7 | MFCD00119122 | 99.8% | 303.17 | C10H8Cl2N4OS | 25MG
iKIX1 is a small-molecule antifungal research compound that disrupts the interaction between the KIX domain of the mediator subunit CgGal11A and the activation domain of CgPdr1, and it resensitizes azole-resistant Candida glabrata in vitro. The compound has formula C10H8Cl2N4OS and a molecular weight of 303.17 g·mol⁻¹; it is supplied for research use only.
- Inhibits KIX-activation domain interaction (IC50 190.2 μM; Ki 18 μM).
- Resensitizes azole-resistant Candida glabrata in vitro.
- Supplied for research use only; not for clinical use.
- High purity (99.8% as reported by manufacturer).
- Stable as powder at -20°C for up to 3 years; in solvent stored at -80°C (6 months) or -20°C (1 month).
- Available as solid and as DMSO solution formulations for convenient handling.
eMolecules 2447575-76-8 | Ambeed | (4R4R)-22-(Heptane-44-diyl)bis(4-phenyl-45-dihydrooxazole) | 100mg | 665578667 | A1505736 | 390.527 | C25H30N2O2
Ambeed | 2-(Phenylethynyl)benzaldehyde | 1g | 524998871 | A108980 | 59046-72-9 | MFCD09030317 | 206.244 | C15H10O
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool<|a>
Medchemexpress LLC 2-Propenamide, 3-(3-chlorophenyl)-N-[2-[4-(methylsulfonyl)-1-piperazinyl]-2-oxoethyl]-, (2E)- | 2505001-54-5 | 99.9% | 385.87 | 50 MG
SR15006 is an inhibitor of Krüppel-like factor 5 (KLF5) with an IC50 of 41.6 nM in DLD-1/pGL4.18hKLF5p cells. It causes a significant reduction in the levels of tested cyclins over 72 hours in DLD-1 CRC cells at concentrations of 1 μM or 10 μM. This product is for research use only.
- Inhibits Krüppel-like factor 5 (KLF5)
- IC50 of 41.6 nM in DLD-1/pGL4.18hKLF5p cells
- Causes a significant reduction in cyclin levels over 72 hours
- Appearance: solid, white to off-white
Medchemexpress LLC SR15006 | 2505001-54-5 | 99.90% | 385.87 | 100 MG
SR15006 is an inhibitor of Krüppel-like factor 5 (KLF5) with an IC50 of 41.6 nM in DLD-1/pGL4.18hKLF5p cells. In vitro studies demonstrated that SR15006 (1 μM or 10 μM) causes a significant reduction in the levels of tested cyclins over 72 hours in DLD-1 CRC cells. This product is for research use only.
- Inhibits Krüppel-like factor 5 (KLF5)
- Exhibits IC50 of 41.6 nM in DLD-1/pGL4.18hKLF5p cells
- Reduces cyclin levels in DLD-1 CRC cells
- For research use only
eMolecules 582-54-7 | AstaTech | (25-DICHLOROPHENOXY)ACETIC ACID | 0.25g | 761944089 | F79703 | 95 | MFCD02127529 | 221.03 | C8H6Cl2O3
AstaTech | (25-DICHLOROPHENOXY)ACETIC ACID | 0.25g | 761944089 | F79703 | 95.000 | 582-54-7 | MFCD02127529 | 221.030 | C8H6Cl2O3
Medchemexpress LLC (R)-preclamol | 85976-54-1 | 99.6% | 219.32 g/mol | C14H21NO | 5 MG
(R)-Preclamol is a dopamine receptor agonist used in neuroscience research to probe dopaminergic signaling. It activates both autoreceptors and postsynaptic dopamine receptors and has been reported to inhibit locomotor activity in mice and rats at low doses. Supplied as a solid and as a 10 mM solution in DMSO for experimental use.
- High chemical purity (99.56%).
- Molecular formula C14H21NO; molecular weight 219.32 g/mol.
- Available as solid and as a 10 mM solution in DMSO.
- Acts at autoreceptors and postsynaptic dopamine receptors.
- Suitable for pharmacology and behavioral studies in rodents.
![Medchemexpress LLC 2-[[(2,6-dichlorophenyl)methyl]thio]-5-(1H-pyrrol-2-yl)-1,3,4-oxadiazole | 2253744-54-4 | 99.9% | 326.20 | C13H9Cl2N3OS | 50MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000238004.png-250.jpg)
Medchemexpress LLC 2-[[(2,6-dichlorophenyl)methyl]thio]-5-(1H-pyrrol-2-yl)-1,3,4-oxadiazole | 2253744-54-4 | 99.9% | 326.20 | C13H9Cl2N3OS | 50MG
Dooku1 is a small-molecule reversible antagonist of Yoda1 that inhibits Yoda1-induced Ca2+ entry in cellular assays. It is provided for research use and is characterized by molecular formula C13H9Cl2N3OS, molecular weight 326.20, and high chemical purity for reliable in vitro experiments.
- Reversible antagonist of Yoda1, suitable for mechanistic studies.
- Demonstrated cellular activity with reported IC50 approximately 1.3 μM for Yoda1-induced Ca2+ entry.
- High purity (>99.9%) for reproducible results.
- Supplied as a compact 50 mg pack for small-scale experiments.
- Applicable to in vitro studies of mechanosensitive ion channel signaling.